Clinical Trial Update: Safety and Immunogenicity of SUM-101 Malaria Vaccine in Children and Infants Living in Burkina Faso [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and immunogenicity of SUM-101 malaria vaccine in children and infants in Burkina Faso.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• SUM-101 malaria vaccine

Snippet

Sponsor: European Vaccine Initiative | Conditions: Malaria,Falciparum | Phase 1 | Status: ACTIVE_NOT_RECRUITING